The numbers of the UK Drug Control Authority showed that the total number of side effects reported to the drug Ozmbek and similar drugs may reach in 2024 to 7,200 cases.
The data collected by the UK’s Pharmaceutical and Pharmaceutical Products Authority consists of reports collected by patients and doctors. Because of the delay in collecting data, the available numbers only cover the period between January and May last year.
The number of cases reported in 2023 was 4 and a half times less than the expected number in 2024, as only 1592 side effects were reported in 2023, according to the Daily Mail.
The side effects that were reported by doctors and patients include severe digestive problems such as stomach paralysis and bowel obstruction, as well as less dangerous complaints such as vomiting and severe bloating.
More than 200 deaths have so far been associated with the Uzbek drug and other drugs from weight reduction, without proving the direct causal relationship. In the United Kingdom, 82 deaths were reported to the organizational authorities, without confirmed links between death and the use of Ozmbek.
Osmbek and Fujofi contains the active substance Semiglotide that mimics the Betide-1 glucagon (GLP-1), a natural hormone secreted in the small intestine when eating.
This chemical sends signals to the brain to feel full, which slows the digestion process and keeps people with full longer and reduces appetite significantly.
Side effects should not be underestimated
Karen Ko, 59, who was taking Monjo (contains the Terzepatide medicine that works similar to Ozmebek) to treat type 2 diabetes, to the Daily Mail, that taking weight losing was like a “stabbing with a knife.”
Mrs. Karen was sent to the house and was asked to monitor her symptoms. She spent 24 hours that followed, suffering from severe pain with stomach cramps, and blood when she went to the bathroom.
Although its symptoms were initially disappeared, she was quickly transferred to the hospital after a week after suffering blood clots, then she was referred to the colon and rectum surgeon in the next two weeks.
Mrs. Karen now urges people to pay attention to the potential side effects of the drug, and warned, “It can cause severe reactions and side effects. People should think carefully and not underestimate it.”
In response, Elie Lily, the pharmaceutical company manufactured by Monjao, said, “The safety of patients is our maximum priority. We take any reports related to the safety of patients seriously, and we monitor and evaluate and report safety information to all of our medications actively. We encourage patients to consult their doctors or other healthcare specialists about any side effects that you may suffer from, and make sure. They obtained the original night medicine. “